$2.47
In chiusura: Nov 12 EDT
$2.36
-0.11-4.45%
Pre-mercato: 9:25 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Oramed Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 25
Stima EPS
$-0.040
Stima dei ricavi trimestrali
–
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$2.00M
Analizza lo storico degli utili di Oramed Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ORMP | Oramed Pharmaceuticals | -$0.48 | -$0.04 | — | — | $0.00 | — | — | — | 11/25/2025 | |
ORMP | Oramed Pharmaceuticals | $0.22 | -$0.04 | $0.13 | 425.00% | $0.00 | — | $2.00M | — | 08/14/2025 | |
ORMP | Oramed Pharmaceuticals | $0.04 | -$0.05 | -$0.19 | -280.00% | $0.00 | $500.00K | $2.00M | 300.00% | 05/15/2025 | |
ORMP | Oramed Pharmaceuticals | $0.33 | -$0.07 | -$0.26 | -271.43% | $0.00 | $0.00 | $0.00 | — | 03/27/2025 | |
ORMP | Oramed Pharmaceuticals | -$0.08 | -$0.07 | -$0.48 | -585.71% | $0.00 | $0.00 | $0.00 | — | 11/07/2024 | |
ORMP | Oramed Pharmaceuticals | -$0.03 | $0.01 | $0.22 | 2100.00% | $674.00K | $250.00K | $0.00 | -100.00% | 08/16/2024 | |
ORMP | Oramed Pharmaceuticals | -$0.08 | $0.02 | $0.04 | 100.00% | $666.00K | — | $0.00 | — | 05/09/2024 | |
ORMP | Oramed Pharmaceuticals | $0.22 | -$0.12 | $0.33 | 375.00% | $681.00K | $0.00 | $0.00 | — | 03/06/2024 | |
ORMP | Oramed Pharmaceuticals | -$0.18 | -$0.08 | -$0.08 | 0.00% | $682.00K | $700.00K | $0.00 | -100.00% | 11/09/2023 | |
ORMP | Oramed Pharmaceuticals | -$0.27 | -$0.11 | -$0.03 | 72.73% | $1.34M | $700.00K | $674.00K | -3.71% | 08/10/2023 | |
ORMP | Oramed Pharmaceuticals | -$0.27 | -$0.26 | -$0.08 | 69.23% | $666.00K | $750.00K | $666.00K | -11.20% | 05/11/2023 | |
ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.19 | $0.22 | 215.79% | $683.00K | $2.95M | $681.00K | -76.92% | 03/06/2023 | |
ORMP | Oramed Pharmaceuticals | -$0.17 | -$0.25 | -$0.18 | 28.00% | $681.00K | $690.00K | $682.00K | -1.16% | 11/10/2022 | |
ORMP | Oramed Pharmaceuticals | -$0.17 | -$0.22 | -$0.27 | -22.73% | $665.00K | — | $674.00K | — | 08/10/2022 | |
ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.23 | -$0.27 | -17.39% | $674.00K | — | $666.00K | — | 05/12/2022 | |
ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.16 | -$0.22 | -37.50% | $674.00K | $700.00K | $674.00K | -3.71% | 01/11/2022 | |
ORMP | Oramed Pharmaceuticals | -$0.10 | -$0.10 | -$0.21 | -110.00% | $681.00K | — | $683.00K | — | 11/24/2021 | |
ORMP | Oramed Pharmaceuticals | $0.10 | -$0.20 | -$0.17 | 15.00% | $681.00K | $970.00K | $681.00K | -29.79% | 07/14/2021 | |
ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.19 | -$0.17 | 10.53% | $674.00K | — | $665.00K | — | 04/13/2021 | |
ORMP | Oramed Pharmaceuticals | -$0.15 | -$0.14 | -$0.23 | -64.29% | $674.00K | $640.00K | $674.00K | 5.31% | 01/14/2021 | |
ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.15 | -$0.10 | 33.33% | $681.00K | — | $681.00K | — | 11/24/2020 |
Oramed Pharmaceuticals (ORMP) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $0.13 | $-0.04 | 425.0 % |
| Q1 | 2025-05-15 | $-0.19 | $-0.05 | -280.0 % |
| Q4 | 2025-03-27 | $-0.26 | $-0.07 | -271.4 % |
| Q3 | 2024-11-07 | $-0.48 | $-0.07 | -585.7 % |
Oramed Pharmaceuticals (ORMP) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | 2025-05-15 | $2.00M | $500.00K | 300.0 % |
| Q2 | 2024-08-16 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-09 | $0 | $700.00K | -100.0 % |
| Q2 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
FAQ
Quando Oramed Pharmaceuticals (NASDAQ:ORMP) riporterà gli utili?
Si prevede che Oramed Pharmaceuticals (ORMP) fornisca risultati il novembre 25, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Oramed Pharmaceuticals (NASDAQ:ORMP)?
L'EPS effettivo era $0.13, che superato la stima di $-0.04.
Quali sono state le entrate di Oramed Pharmaceuticals (NASDAQ:ORMP)?
Le entrate effettive sono state $2M, che superato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.